Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Entourage Health Corp. (ETRGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0768+0.0024 (+3.20%)
At close: 03:55PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0744
Open0.0630
BidN/A x N/A
AskN/A x N/A
Day's Range0.0630 - 0.0796
52 Week Range0.0500 - 1.0000
Volume57,239
Avg. Volume200,918
Market Cap23.345M
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-0.2850
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ETRGF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ENTOURAGE HEALTH CORP
    Daily – Vickers Top Buyers & Sellers for 12/28/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    21 days agoArgus Research
View more
  • GlobeNewswire

    Entourage Health Posts New Year 2022 Shareholder Newsletter

    TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022. The Company overview and Shareholder Newsletter is posted on Entourage’s webs

  • CNW Group

    IIROC Trading Resumption - ENTG

    Trading resumes in:

  • GlobeNewswire

    Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing

    Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed MedicinalTORONTO, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has amended its existing credit facility (“Credit Facil

Advertisement
Advertisement